Brian Yoor

Collaborative and strategic financial leader of a $150Bn market cap global healthcare leader. Responsible for the functions of Accounting, FP&A, Treasury, Tax, Investor Relations, Internal Audit, Economics, Procurement, IT, M&A, and transition office for major corporate initiatives. Interact significantly with investor community, responsible for communicating the company’s identity, financial results, and shareholder value proposition. • Developed financing strategy to secure $30Bn debt financing facility in for the largest acquisitions made in Abbott’s history. Rapidly paid down debt to achieve unprecedented multiple credit rating upgrades within a 12 month period. • Responsible for annual business planning process and delivery of the Plan and financial forecasts to the Board. • Organized around key talent to plan and implement a global program to significantly improve free cash flow. Program includes all businesses and addresses working capital, capital expenditures, treasury and tax strategies. • Active leader with the investor community, including both sell and buy-side analysts and portfolio managers. Market capitalization has more than doubled since time in CFO role. • Launched rolling forecast analysis tools, including market models to develop financial targets for 4 diverse global business segments of Abbott. Lead selective monthly business reviews to ensure we are on track with our strategic and financial commitments. • With Tax team, undertook complex scenario-planning and achieved superior results around tax reform and related capital allocation. • Leading a global "Future of Finance" program that addresses leading indicators, the data and technologies to sustain measurement of key indicators, critical thinking skills, and executive communication. • Implemented program to combine Shared Service model with other financial back-office financial functions to generate significant savings.

Reporting to the CFO, lead fortune 200 Investor Relations group to achieve fair market value for $60 billion of investment. Responsible for establishing and communicating the company’s financial identity, or brand, to worldwide investors and sell-side analysts. Role includes significant interaction with the CEO, executive staff, and external investment community. •Expertise with investors around separations, M&A, emerging markets, and company “crises-like” events. •Developed a new investor identity in conjunction with the company's separation into two leading fortune 200 healthcare companies. The new equity story was unveiled during the 2012 CEO road-shows. •Built and maintained a fair valuation that is among the top of its peer group. •Improved analyst engagement resulting in a “Buy” recommendation ratio of x% among sell-side analysts. •Represent 4 diverse, global business segments with 40% of sales being generated in emerging markets. •Developed an Investor Relations strategy for the "new" Abbott that incorporates best practice elements of what and how to communicate with the investment community. •Launched new press release format in first three months that addresses all of the segment results and incorporates the investment identity themes of the “new” Abbott. Extremely well received by the “street”. •Established a national accounts selling approach that is grounded in analytics to target investors, protect and retain key investments, and explore funds beyond traditional healthcare. Established early key account wins of long and growth-oriented firms in conjunction with identity. •Launched new rolling forecast analyses tools, including market models to develop 3 year financial targets for 4 diverse global business segments of Abbott.